secwatch.observer — SEC 8-K summary
======================================

Issuer:     Rani Therapeutics Holdings, Inc. (RANI)
CIK:        0001856725
Form:       8-K
Filed at:   2024-07-23T23:59:59+00:00
Accession:  0001193125-24-182549
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Rani Therapeutics raises $10M via registered direct offering with warrants
--------------------------------------------------------------------------

- Gross proceeds ~$10M from sale of 2.8M shares, 446,753 pre-funded warrants, and warrants for 6.5M shares.
- Combined offering price $3.08 per share/warrant unit; warrants exercisable at $3.08 starting six months after closing.
- Series A warrants expire 18 months from issuance; Series B warrants expire 5.5 years from issuance.
- Directors and officers subject to 60-day lock-up; company restricted from issuing new securities for up to 60 days.
- Closing expected July 23, 2024; Maxim Group acted as placement agent with 6% fee.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1856725/000119312524182549/0001193125-24-182549-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1856725/000119312524182549/d873880d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-182549

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer